Zoan BioMed was the first company to be introduced at the conference – ‘Bringing Blue Innovation to the Market’. We presented our business and detailed our commercialisation plans after FDA approval. Of particular interest was the sustainability credentials of the Zoan BioMed platform – the first company in its industry to commit towards a short term goal of being carbon neutral in its production facility. Thank you to moderator Vincent Favrel and all our friends at the European Climate, Infrastructure and Environment Executive Agency.
Thank you to the Cellink team for hosting us in their highly impressive facility in Gothenberg.
We are making excellent progress towards our development of 3D bioprinted tissue model containing sustainably grown coral skeletal particles.
Zoan and partners at TERMIS 2023
Zoan, Cellink and University of Galway collaboration on 3D printable coral-containing bioinks to present results at TERMIS, Manchester, 28-31st March 2023: Biocompatibility of 3D bioprinted tissue model prototypes containing sustainably grown coral skeletal particles for orthopedic applicationsE. Pernevik et. al. Zoan and partners at CELLINK and University of Galway will be presenting the early results from our coral bioink…
Our Sustainability Model
As a Med Tech company that aims to improve people’s health, we recognise the need to preserve a healthy environment. The link between human and environmental health is well established: the WHO states that one in four premature deaths is related to environmental issues caused by humans and the World Bank acknowledges that sustainable management…
Novel Collaboration between Zoan Biomed and University of Galway to Assess Laboratory Bone Formation
Zoan Biomed and the University of Galway to develop high throughput rapid assessment methods for biocompatibility and osteogenic potential of orthopaedic scaffold; reducing time to clinical data and developing a path to remove the need for animal testing.
To find out more about Zoan BioMed get in touch